For Members

Coarctation, a condition which comprises 4-5% of all congenital heart disease cases, is the second most common congenital heart defect  requiring neonatal intervention. Yet there is a lack of guidance regarding aspects of its management in neonates and infants, primarily due to heterogeneity in phenotype, making consensus in management challenging.

Recently, the STS Workforce on Evidenced-Based Surgery and its Task Force on Congenital Heart Surgery formed a panel of congenital cardiac surgeons, cardiologists, and intensivists to provide guidance to specialists who manage isolated coarctation in neonates and infants¹. 

Methods

The multi-disciplinary Task Force members first identified key questions related to the care of these patients using the PICO Framework (Patients/Population, Intervention, Comparison/Control, Outcome). After performing a literature search for each question, practice guidelines were developed using a modified Delphi method with a “recommendation” classification and evidence level, which were graded using Class of Recommendations (COR) and Level of Evidence (LOE) based on AAC/AHA classification system².

Results

The following recommendations reached a “consensus,” which meant that 80% of panel members voted on them, and 75% of them agreed with these statements:  

• For neonates and infants with isolated coarctation, surgery is indicated in the absence of obvious surgical contraindications for those with prematurity, low weight, or other risk factors for surgical intervention. 
• For patients with risk factors for surgery, medical management prior to intervention is reasonable. 
• For those without associated arch hypoplasia, repair via thoracotomy is indicated. 
• For those with associated arch hypoplasia that cannot be adequately addressed via thoracotomy, repair via sternotomy is preferable. 
• For those with bovine arch anatomy, repair via sternotomy may be reasonable given the potential increased risk of recoarctation with bovine arch anatomy repaired via thoracotomy
• For those undergoing repair via sternotomy, antegrade cerebral perfusion or limited duration deep hypothermic circulatory arrest may be reasonable
• For those undergoing repair via sternotomy, extended end-to-end, arch advancement (end-to-side reconstruction with ligation of isthmus), and patch augmentation are all reasonable techniques

Conclusions

After completing the evaluation, Task Force members concluded that surgery remains the standard of care for managing isolated coarctation in neonates and infants. Depending on degree and location, arch hypoplasia may require a sternotomy approach rather than a thoracotomy approach. Significant opportunities remain to delineate management in these patients better.

Although these statements provide guidance considering the available data, they are not intended to be prescriptive, and practitioners should apply these based on their experience, as well as within the clinical setting in which they work.

"Some of these guidelines' most valuable aspects summarize the data related to thoracotomy vs. sternotomy, which is a continued area of debate," said the study's lead author, Dr. Elizabeth Stephens, associate professor of surgery at Mayo Clinic in Rochester, Minn.  "The decision is often relatively subjective and based on the surgeon's training and/or experience."

This paper reveals the many questions that still need to be studied and answered. "The good news is that we as a specialty have moved from ensuring survival in these patients to decreased morbidities related to surgery, but the next step is studying long-term outcomes and how to improve them, namely freedom from hypertension and late reintervention," added Dr. Stephens.

Read the Annals article, which will soon be published in the upcoming September 2024 issue (Vol 118, No. 3) of The Annals of Thoracic Surgery. 

References:

1. Stephens EH, Ahmad D, Alsoufi B, Anderson BR, Ashfaq A, Bleiweis MS, Dearani JA, d’Udekem Y, Feins EN, Jacobs JP, Karamlou T, Marino BS, Najm HK, Nelson JS, St. Louis JD, Turek JW, The Society of Thoracic Surgeons Clinical Practical Guidelines on the Management of Neonates and Infants with Coarctation, The Annals of Thoracic Surgery (2024)

2. Class of Recommendation (COR) and Level of Evidence (LOE); Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 67(13), 1572–1574. https://doi.org/10.1016/j.jacc.2015.09 

Two papers recently published in The Annals of Thoracic Surgery aim to guide the management of thymoma¹ and pleural drains following pulmonary lobectomy² – thoracic conditions and treatments that lack widely accepted guidelines. Recognizing this need, the Society of Thoracic Surgeons (STS) Workforce on Evidenced-Based Surgery convened a task force to develop expert consensus documents to help alleviate this knowledge gap.

Thymoma, a rare epithelial tumor – but also the most common anterior mediastinal tumor in adult patients – is a condition thoracic surgeons will likely encounter as clinicians. However, there is a lack of evidence covering all aspects of treatment due to its relatively low incidence. Managing pleural drains following pulmonary lobectomy is standard practice, yet there are no established guidelines on this topic despite abundant published literature.

Management of thymoma

The STS Workforce on Evidence-Based Surgery, which includes general thoracic surgeons with expertise in thoracic surgical oncology, and medical and radiation oncologists with expertise in neoadjuvant and adjuvant therapies, evaluated existing literature about surgical considerations in managing thymomas, such as:

•    Imaging characteristics
•    Diagnostic tests 
•    Staging 
•    Surgical approach and technique
•    Neoadjuvant and adjuvant therapy 
•    Surgery for advanced or recurrent disease, and 
•    Postoperative surveillance

Consensus statements were drafted using the modified Delphi method. Votes for each proposed statement were tallied using a 5-point Likert scale, with the option to abstain on those not within the specific authors’ expertise. Statements with 75% of responding authors selecting “agree” or “strongly agree” were considered to have reached a consensus. 

Unlike broader guidelines encompassing various aspects of thymoma management, including medical oncology, radiology, and pathology, this paper addresses thymoma from a surgical perspective by guiding surgical interventions, especially in metastatic and recurrent diseases.

"Given the scarcity of randomized controlled trials due to the rarity of thymoma, this document is framed as an expert consensus rather than strict evidence-based clinical practice guidelines," said the study's lead author, Dr. Douglas Liou, clinical associate professor at Stanford Medicine. "Our findings rely more heavily on the combined experience and judgment of experts in the field rather than solely on data from large-scale studies." 

Read the Annals article. 

Management of pleural drains following pulmonary lobectomy

Similarly, the consensus document developed by the STS Workforce on Evidence-Based Surgery to manage pleural drains includes:

•    Choice of drain, including size, type, and number
•    Management, such as use of suction versus waterseal and criteria for removal
•    Imaging recommendations, including the use of daily and post-pull chest x-rays
•    Use of digital drainage systems, and
•    Management of prolonged air leak

Workforce members reviewed existing literature on the condition. A consensus using a modified Delphi method consisting of two rounds of voting until 75% agreement on the statements was reached, with a total of thirteen statements that encouraged standardization and stimulated additional research in this critical area. 

“Optimal management of these drains should reduce patient discomfort, length of stay, and complications.”  said study investigator Dr. Michael Kent, associate professor of surgery at Harvard Medical School. “However, despite how commonly chest tubes are used in practice, the literature must provide more clarity on this subject. Many important questions have yet to be addressed and may require well-designed, prospective randomized trials.”

Read the Annals article. 

1. Reference: Liou DZ, Berry MF, Brown LM, Demmy TL, Huang J, Khullar OV, Padda SK, Shah RD, Taylor MD, Toker SA, Weiss E, Wightman SC, Worrell SG, Hayanga JWA, The Society of Thoracic Surgeons Expert Consensus Document on the Surgical Management of Thymomas, The Annals of Thoracic Surgery (2024)

2. Reference: Kent MS, Mitzman B, Diaz-Gutierrez, I, Khullar OV, Fernando H, Backus L, Brunelli A, Cassivi SD, Cerfolio RJ, Crabtree TD, Kakuturu J, Martin LW, Worrell SG, Raymond DP, Schumacher L, Hayanaga JWA, The Society of Thoracic Surgeons Expert Consensus Document on the Management of Pleural Drains following Pulmonary Lobectomy, The Annals of Thoracic Surgery (2024)

As key members of the multidisciplinary care team, thoracic surgeons play a pivotal role in the patient journey for resectable Non-Small Cell Lung Cancer. This patient journey map, suitable for both surgeons and patients, outlines the stages of treatment of resectable NSCLC from diagnosis and staging, to resection, referral to a medical oncologist, and surveillance. This includes consideration of biomarker testing during the diagnostic biopsy and resection stages, and the potential benefit of perioperative and adjuvant therapies.

Click the image below to view or download the full document.

Image

Additional Resources

Webinars 

• Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC
• Sublobar Resection Versus Lobectomy for Early-Stage Lung Cancer: A Debate

Video 

• The Surgeon’s Role in Managing Patients with Resectable NSCLC

The House and Senate just approved a new government funding bill that provides $730 million in relief from Medicare physician payment cuts, boosting reimbursements by 1.68% starting on March 9 and lasting through the end of 2024. 
 
STS has vigorously advocated for this relief, yet the total amount is less than what many stakeholders demanded, including STS, 30 members of the U.S. Senate, and nearly 200 members of the U.S. House of Representatives. We will continue to advocate for the elimination of all payment cuts and insist on systematic reforms that eliminate this threat. This includes H.R. 2474, a bipartisan bill with broad support that would create automatic annual inflation adjustments for Medicare physician payments. Contact Congress on this important issue. 
 
Additional Details

• The relief will apply to services rendered between March 9 and Dec. 31, 2024. 
• After applying the relief, Medicare payments will remain 1.69% lower than in 2023. 
• The payment reduction relief will not apply to claims between Jan. 1 and March 8, 2024. 
• On Jan. 1, 2025, an additional reduction of at least 2.93% will occur, absent congressional action, due to the expiration of temporary relief.

If you have questions, contact advocacy@sts.org.

During this session, investigators unveiled findings from the largest multicenter study of post-arterial switch operations (ASO) that resulted in increased survival rates for adolescents and adult patients – as well as an increase in the potential for these patients to require cardiac reoperations to address arterial switch related complications that arise later in life.

At day two's presentation on “Burden of Reoperative  Cardiac Surgery among Adolescents and Adults Who Have Undergone Prior Arterial Switch Operation: Society of Thoracic Surgeons Database Analysis,” Bret Mettler, MD, from Johns Hopkins University, examined a multi-year assessment of the prevalence and types of cardiac surgical interventions in patients who previously underwent ASO using data from the STS National Database. 

“Anatomical repair of transposition of the great arteries (TGA) and related anomalies by arterial switch operation (ASO) achieves a normal anatomic and physiologic cardiac configuration,” said Dr. Mettler.  “And as survival rates have increased, so have the potential for these patients to require cardiac reoperations to address resulting ASO-related complications.”

As most reoperations involved multiple procedures, the presentation examined how a hierarchical stratification of procedure categories was established, with each eligible surgical hospitalization assigned to the single highest applicable hierarchical category.
  
Dr. Mettler's presentation also examined implications for surgical counseling, post-operative clinical surveillance, and therapeutic management. An analysis of the role of procedural prevalence, timing, categories, trends, and the growing number of reoperations was discussed.

“Over the past year, the STS has reaffirmed our mission to improve the lives of patients with cardiothoracic disease. We have revised our strategic plan and identified three top priorities: champion the value and impact of the specialty; advance the health, well-being, and inclusion of all cardiothoracic surgeons; and enhance the STS member value and educational experience.

It’s been an extraordinary year. We have been champions of the specialty and champions of each other. Thank you for the honor of being your president.”

STS President Dr. Tom MacGillivray

The Hub made its debut at STS 2024. In the Exhibit Hall, meeting participants attended the "Early Career Journey Roundtable: Trade Secrets for a Successful Career Journey," creating peer-to-peer connections while networking. 

Watch our day two wrap-up video!

Watch our day three wrap-up video!

Cardiothoracic surgeons provide tremendous value to the patients and institutions they serve. But understanding their value and translating it into fair compensation has always been challenging. While there are external resources that provide general guidance on surgeon compensation, there are no compensation surveys that capture the nuances of the specialty. Until now.

STS has commissioned Gallagher, a consulting firm with more than four decades of experience in physician compensation and valuation services, to conduct a first-of-its-kind compensation survey in early October to help CT surgeons practicing in the U.S. understand their value in the market specific to their specialty, practice, career stage, and geographic region. Data collected will be kept confidential and will not be shared with STS.

A compensation report, featuring only aggregated data consistent with federal guidelines to ensure data integrity and anonymity, will make it easier for CT surgeons to evaluate employment opportunities and negotiate salaries and benefits.

The compensation report—slated for release January 2024—will be available to STS surgeon members who participate in the survey at no cost, and to STS members and nonmembers who do not participate in the survey for a fee.

How To Participate in the STS Compensation Survey

Non-resident/trainee CT surgeons should have received an email with instructions on how to complete the survey from Gallagher or you can access the survey here. The survey should take about 15 minutes to complete.

Participants should have their 2022 W-2 (or equivalent income documentation), compensation plan, and associated annual compensation calculations and productivity (e.g., wRVUs, etc.) reports at hand before they begin. Participants should contact their practice administrator if they do not have access to the required documentation.

Deadline for completing the survey is October 27, 2023.

If you have questions or do not receive an email invitation but wish to participate, email jenna_lambrecht@ajg.com.